Anebulo Pharmaceuticals, Inc. (ANEB): Price and Financial Metrics
ANEB Price/Volume Stats
Current price | $1.45 | 52-week high | $3.30 |
Prev. close | $1.57 | 52-week low | $0.80 |
Day low | $1.45 | Volume | 2,272 |
Day high | $1.61 | Avg. volume | 15,491 |
50-day MA | $1.51 | Dividend yield | N/A |
200-day MA | $2.00 | Market Cap | 37.60M |
ANEB Stock Price Chart Interactive Chart >
Anebulo Pharmaceuticals, Inc. (ANEB) Company Bio
Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing treatments for patients suffering from cannabinoid overdose and addiction. Its lead product candidate is ANEB-001, a small molecule cannabinoid receptor antagonist to treat cannabinoid overdose. The company was incorporated in 2020 and is based in Lakeway, Texas.
ANEB Price Returns
1-mo | -0.68% |
3-mo | -12.12% |
6-mo | -24.68% |
1-year | -41.53% |
3-year | -78.33% |
5-year | N/A |
YTD | -13.69% |
2024 | -30.58% |
2023 | -0.15% |
2022 | N/A |
2021 | N/A |
2020 | N/A |
Loading social stream, please wait...